Distinct characteristics of e13a2 versus e14a2 BCR-ABL1 driven chronic myeloid leukemia under first-line therapy with imatinib
B. Hanfstein, M. Lauseker, R. Hehlmann, S. Saussele, P. Erben, C. Dietz, A. Fabarius, U. Proetel, S. Schnittger, C. Haferlach, S. W. Krause, J. Schubert, H. Einsele, M. Hanel, J. Dengler, C. Falge, L.Year:
2014
Language:
english
DOI:
10.3324/haematol.2013.096537
File:
PDF, 766 KB
english, 2014